Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

High-mobility group box 2 is associated with prognosis of glioblastoma by promoting cell viability, invasion, and chemotherapeutic resistance.

Wu ZB, Cai L, Lin SJ, Xiong ZK, Lu JL, Mao Y, Yao Y, Zhou LF.

Neuro Oncol. 2013 Sep;15(9):1264-75. doi: 10.1093/neuonc/not078.

2.

Overexpression of high-mobility group box 2 is associated with tumor aggressiveness and prognosis of hepatocellular carcinoma.

Kwon JH, Kim J, Park JY, Hong SM, Park CW, Hong SJ, Park SY, Choi YJ, Do IG, Joh JW, Kim DS, Choi KY.

Clin Cancer Res. 2010 Nov 15;16(22):5511-21. doi: 10.1158/1078-0432.CCR-10-0825.

3.

Annexin A5 promotes invasion and chemoresistance to temozolomide in glioblastoma multiforme cells.

Wu L, Yang L, Xiong Y, Guo H, Shen X, Cheng Z, Zhang Y, Gao Z, Zhu X.

Tumour Biol. 2014 Dec;35(12):12327-37. doi: 10.1007/s13277-014-2545-1.

PMID:
25245332
4.

Overexpression of CD97 confers an invasive phenotype in glioblastoma cells and is associated with decreased survival of glioblastoma patients.

Safaee M, Clark AJ, Oh MC, Ivan ME, Bloch O, Kaur G, Sun MZ, Kim JM, Oh T, Berger MS, Parsa AT.

PLoS One. 2013 Apr 26;8(4):e62765. doi: 10.1371/journal.pone.0062765.

5.

O6-Methylguanine-DNA methyltransferase is a novel negative effector of invasion in glioblastoma multiforme.

Chahal M, Abdulkarim B, Xu Y, Guiot MC, Easaw JC, Stifani N, Sabri S.

Mol Cancer Ther. 2012 Nov;11(11):2440-50. doi: 10.1158/1535-7163.MCT-11-0977.

6.

Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells.

Tchoghandjian A, Jennewein C, Eckhardt I, Rajalingam K, Fulda S.

Cell Death Dis. 2013 Mar 28;4:e564. doi: 10.1038/cddis.2013.70.

7.

MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1.

Liu Y, Yan W, Zhang W, Chen L, You G, Bao Z, Wang Y, Wang H, Kang C, Jiang T.

Oncol Rep. 2012 Sep;28(3):1013-21. doi: 10.3892/or.2012.1902.

PMID:
22766851
8.

Inhibition of STAT3 reduces astrocytoma cell invasion and constitutive activation of STAT3 predicts poor prognosis in human astrocytoma.

Liang Q, Ma C, Zhao Y, Gao G, Ma J.

PLoS One. 2013 Dec 30;8(12):e84723. doi: 10.1371/journal.pone.0084723.

9.

Role of glycosyltransferase PomGnT1 in glioblastoma progression.

Lan J, Guo P, Lin Y, Mao Q, Guo L, Ge J, Li X, Jiang J, Lin X, Qiu Y.

Neuro Oncol. 2015 Feb;17(2):211-22. doi: 10.1093/neuonc/nou151.

10.

PAX6 suppresses the invasiveness of glioblastoma cells and the expression of the matrix metalloproteinase-2 gene.

Mayes DA, Hu Y, Teng Y, Siegel E, Wu X, Panda K, Tan F, Yung WK, Zhou YH.

Cancer Res. 2006 Oct 15;66(20):9809-17.

11.

FOXC2 often overexpressed in glioblastoma enhances proliferation and invasion in glioblastoma cells.

Li W, Fu X, Liu R, Wu C, Bai J, Xu Y, Zhao Y, Xu Y.

Oncol Res. 2013;21(2):111-20. doi: 10.3727/096504013X13814233062171.

PMID:
24406047
12.

Differential effects of low- and high-dose GW2974, a dual epidermal growth factor receptor and HER2 kinase inhibitor, on glioblastoma multiforme invasion.

Wang L, Liu Q, Zhao H, Cui K, Yao L, Nie F, Jin G, Hao A, Wong ST.

J Neurosci Res. 2013 Jan;91(1):128-37. doi: 10.1002/jnr.23140.

PMID:
23115024
13.

miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion.

Fowler A, Thomson D, Giles K, Maleki S, Mreich E, Wheeler H, Leedman P, Biggs M, Cook R, Little N, Robinson B, McDonald K.

Eur J Cancer. 2011 Apr;47(6):953-63. doi: 10.1016/j.ejca.2010.11.026.

PMID:
21196113
14.

STAT6 expression in glioblastoma promotes invasive growth.

Merk BC, Owens JL, Lopes MB, Silva CM, Hussaini IM.

BMC Cancer. 2011 May 20;11:184. doi: 10.1186/1471-2407-11-184.

15.

SPOCK1 is upregulated in recurrent glioblastoma and contributes to metastasis and Temozolomide resistance.

Yu F, Li G, Gao J, Sun Y, Liu P, Gao H, Li P, Lei T, Chen Y, Cheng Y, Zhai X, Sayari AJ, Huang H, Mu Q.

Cell Prolif. 2016 Apr;49(2):195-206. doi: 10.1111/cpr.12241.

PMID:
26923184
16.

Prognostic significance of CD147 in patients with glioblastoma.

Yang M, Yuan Y, Zhang H, Yan M, Wang S, Feng F, Ji P, Li Y, Li B, Gao G, Zhao J, Wang L.

J Neurooncol. 2013 Oct;115(1):19-26. doi: 10.1007/s11060-013-1207-2.

PMID:
23925827
17.

The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas.

Wu ZB, Cai L, Lin SJ, Lu JL, Yao Y, Zhou LF.

Brain Res. 2013 Sep 5;1529:16-25. doi: 10.1016/j.brainres.2013.07.031.

PMID:
23892108
18.

MUC4 modulates human glioblastoma cell proliferation and invasion by upregulating EGFR expression.

Li W, Wu C, Yao Y, Dong B, Wei Z, Lv X, Zhang J, Xu Y.

Neurosci Lett. 2014 Apr 30;566:82-7. doi: 10.1016/j.neulet.2014.02.033.

PMID:
24582898
19.

TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients.

Wang C, Cao S, Yan Y, Ying Q, Jiang T, Xu K, Wu A.

BMC Cancer. 2010 Aug 10;10:415. doi: 10.1186/1471-2407-10-415.

20.

Supplemental Content

Support Center